Moneycontrol PRO
HomeNewsOpinionChart of the Day: Reshoring pharma? Why the US can’t afford to disrupt generic drug supply

Chart of the Day: Reshoring pharma? Why the US can’t afford to disrupt generic drug supply

As US lawmakers push to reshore pharmaceutical production, a crucial question remains—are they focusing on the right cost drivers in healthcare?

April 01, 2025 / 09:17 IST
The US spends significantly lower amounts on generic drugs compared to other healthcare services
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts